enGene Holdings Inc. (NASDAQ: ENGN) Stock Information | RedChip

enGene Holdings Inc. (NASDAQ: ENGN) Listen to this Section


$5.75
-0.1500 ( -2.54% ) 10.9K

enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Market Data


Open


$5.75

Previous close


$5.90

Volume


10.9K

Market cap


$268.97M

Day range


$5.48 - $6.13

52 week range


$5.10 - $43.00

Insider Ownership Transactions

Total Amount Purchased: -2,357,789.00 | $ -13,557,286.75

Date Type Amount Purchased Purchaser
2024-03-25 Sale -40000.00 Zoth Lota S.
2024-03-20 Sale -52940.00 CHEUNG ANTHONY TZEYEW
2024-03-19 Sale -225000.00 Giguere Lee
2024-02-21 Sale -644965.00 BRUNK GERALD A
2024-02-21 Sale -644965.00 Lumira Capital Investment Management Inc.
2023-12-04 Sale -153000.00 BRYCE RICHARD PAUL
2023-12-04 Sale -232000.00 Daws D. Ryan
2023-11-02 Sale -177935.00 Nichols Alexander Julian
2023-11-02 Sale -49933.00 CHEUNG ANTHONY TZEYEW
2023-11-02 Sale -137051.00 Hanson Jason David

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Jun 18, 2024
8-k 8K-related 35 Jun 14, 2024
10-q Quarterly Reports 82 Jun 14, 2024
4 Insider transactions 1 May 29, 2024
3 Insider transactions 2 May 17, 2024
3 Insider transactions 2 May 17, 2024
8-k 8K-related 12 May 15, 2024
4 Insider transactions 1 Apr 22, 2024
ars Annual reports 1 Apr 18, 2024
def Proxies and info statements 4 Apr 18, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.